Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Gilead’s HIV treatment demonstrates high efficacy and viral suppression at five years

February 14, 2022 Sales and Marketing

Gilead Sciences has announced the presentation of cumulative five-year results from two Phase III studies of Biktarvy. The new, long-term …
News

First UK Lassa fever death in over a decade

February 14, 2022 Sales and Marketing

A patient in Bedfordshire has died from a confirmed case of Lassa fever, the UK Health Security Agency (UKHSA) has …
News
fejiomfxwaeana8

First gene therapy for rare genetic neurodegenerative disorder in children

February 7, 2022 Sales and Marketing

NICE has published a draft highly specialised technologies guidance, recommending gene therapy atidarsagene autotemcel for some children with the rare, …
News

NICE approves new treatment for chronic heart failure

February 7, 2022 Sales and Marketing

Empagliflozin (Jardiance®) has received a positive NICE recommendation for the treatment of chronic heart failure. NICE has announced that empagliflozin …
News

FDA approves Vabysmo to treat vision-threatening retinal conditions

January 31, 2022 Sales and Marketing

The FDA has approved vabysmo (faricimab-svoa) for the treatment of neovascular or “wet” age-related macular degeneration and diabetic macular edema. …
News

Almirall announces licensing agreement to accelerate antibody drug discovery

January 31, 2022 Sales and Marketing

Almirall has announced a multi-target licensing agreement with Ablexis, focussed on licensing its AlivaMab Mouse technology, and a research collaboration …
News

Positive CHMP opinion for treatment of rare unpredictable disease

January 31, 2022 Sales and Marketing

Blueprint Medicines has announced that the CHMP has adopted a positive opinion recommending to expand the current indication for AYVAKYT® …
News

CHMP recommends approval of dupixent for children with severe asthma

January 31, 2022 Sales and Marketing

The EMA’s CHMP has adopted a positive opinion recommending the extension of the approval of Dupixent (dupilumab) for children with …
News

Ascletis begins Phase III trial into bevacizumab for treatment of recurrent glioblastoma

January 24, 2022 Sales and Marketing

Ascletis Pharma has announced the dosing of the first patient in the Phase III registration clinical trial of ASC40, combined …
News

Pfizer: Annual COVID shots preferable to frequent boosters

January 24, 2022 Sales and Marketing

Pfizer CEO Albert Bourla has commented that an annual COVID-19 vaccine would be preferable to more frequent booster shots in …
News

NICE expands guidance for lokelma in adult patients with persistent hyperkalaemia

January 24, 2022 Sales and Marketing

NICE have updated the Technology Appraisal Guidance (TAG) for Lokelma (sodium zirconium cyclosilicate SZC) in the treatment of adult patients …
News

Veklury obtains FDA approval for COVID-19 outpatients

January 24, 2022 Sales and Marketing

The FDA has granted expedited approval of a supplemental new drug application (sNDA) for Veklury (remdesivir) for he treatment of …
News

Neurimmune and Ono Pharmaceutical collaborate to research neurodegenerative diseases

January 17, 2022 Sales and Marketing

Neurimmune AG has signed an expanded drug discovery collaboration agreement with Ono Pharmaceutical. The companies aim to focus on creating …
News

NICE draft guidance recommends new treatment for rare liver condition

January 17, 2022 Sales and Marketing

On Friday 14 January, NICE published a final draft Highly Specialised Technologies guidance, recommending odevixibat in line with its marketing …
News

FDA places Alzheimer’s therapeutic IND Application on hold

January 17, 2022 Sales and Marketing

The FDA has placed a hold on the Investigational New Drug (IND) application for DNL919, indicating they will provide an …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025